ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 992,87
0,00%
Dow Jones
38 686,32
1,51%
DAX
18 497,94
-0,09%
Brent Oil
80,725
-0,10%
Bitcoin
68 893,56
1,69%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. InMed Pharmaceuticals Inc (INM)

  7. InMed Pharmaceuticals Inc (INM) Actualités

INM

InMed Pharmaceuticals (INM)

InMed Pharmaceuticals Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:INM
DateHeureSourceTitreSymboleSociété
28/05/202422h27Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INMInMed Pharmaceuticals Inc
14/05/202422h12Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INMInMed Pharmaceuticals Inc
27/02/202421h27Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:INMInMed Pharmaceuticals Inc
13/02/202423h05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:INMInMed Pharmaceuticals Inc
21/12/202323h21Edgar (US Regulatory)Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]NASDAQ:INMInMed Pharmaceuticals Inc
14/11/202306h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:INMInMed Pharmaceuticals Inc
13/11/202323h05Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:INMInMed Pharmaceuticals Inc
08/11/202323h05Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:INMInMed Pharmaceuticals Inc
27/10/202322h08Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:INMInMed Pharmaceuticals Inc
27/10/202322h04Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:INMInMed Pharmaceuticals Inc
29/09/202317h43Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:INMInMed Pharmaceuticals Inc
29/09/202317h30Edgar (US Regulatory)Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405NASDAQ:INMInMed Pharmaceuticals Inc
25/05/202318h37Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:INMInMed Pharmaceuticals Inc
17/05/202300h00Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INMInMed Pharmaceuticals Inc
15/05/202317h47Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:INMInMed Pharmaceuticals Inc
10/03/202314h35GlobeNewswire Inc.Life Sciences Virtual Investor Forum: Presentations Now Available for Online ViewingNASDAQ:INMInMed Pharmaceuticals Inc
07/03/202314h35GlobeNewswire Inc.Life Sciences Virtual Investor Forum Agenda Announced for March 9thNASDAQ:INMInMed Pharmaceuticals Inc
20/02/202317h00GlobeNewswire Inc.InMed Reports Second Quarter Fiscal 2023 Financial Results and Provides Business UpdateNASDAQ:INMInMed Pharmaceuticals Inc
14/02/202318h59Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:INMInMed Pharmaceuticals Inc
10/02/202312h09Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:INMInMed Pharmaceuticals Inc
10/02/202303h40GlobeNewswire Inc.InMed Submits Form 12b-25NASDAQ:INMInMed Pharmaceuticals Inc
10/01/202313h30GlobeNewswire Inc.InMed Provides Business Update and Milestones for 2023NASDAQ:INMInMed Pharmaceuticals Inc
16/12/202200h17GlobeNewswire Inc.InMed Announces Results of 2022 Annual General MeetingNASDAQ:INMInMed Pharmaceuticals Inc
15/12/202217h44Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:INMInMed Pharmaceuticals Inc
15/12/202212h43Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:INMInMed Pharmaceuticals Inc
13/12/202200h47GlobeNewswire Inc.InMed Announces Appointment of Interim Chief Financial Officer and Change of AuditorNASDAQ:INMInMed Pharmaceuticals Inc
07/12/202222h37Edgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:INMInMed Pharmaceuticals Inc
06/12/202212h02Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:INMInMed Pharmaceuticals Inc
21/11/202223h00GlobeNewswire Inc.InMed Pharmaceuticals Announces Closing of $6 Million Private Placement Priced at a Premium to MarketNASDAQ:INMInMed Pharmaceuticals Inc
18/11/202214h00GlobeNewswire Inc.InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to MarketNASDAQ:INMInMed Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:INM

Dernières Valeurs Consultées

LSE
83GD
Inter-amer 23
TSXV
XGC
Xali Gold
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés